2 active trials 1 recruiting 1 Phase 3 1 disease areas
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-08-27 | NCT07789379 Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma | Phase 2 | Not Yet Recruiting |
| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05527470 | Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally… | Nasopharyngeal Carcinoma | Recruiting | 2023-05-03 |
| Phase 2 | ||||
| NCT07789379 | Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma | Glioblastoma | Not Yet Recruiting | 2026-08-27 |
Glioblastoma (1)